---
title: "Letybo®"
---

## What is Letybo®?

Letybo® is a neuromodulator for frown lines, the vertical lines between your brows, approved in the US in 2024 [1]. Like other neuromodulators, it relaxes the muscles behind those lines, so the skin above them smooths out and you look rested and refreshed.

It was studied in three large clinical trials [2], and it works quickly: results can show in as little as one to three days [3].

## Why choose Letybo® at MD TLC™?

At MD TLC™, [Dr. Quibell](/providers/dianne-quibell-md/) performs every injection herself. She is an internationally renowned physician and educator who has trained several thousand clinicians in laser and light-based technology, injectables and other regenerative therapies.

She offers every leading neuromodulator, including [BOTOX® Cosmetic](/treatments/botox-cosmetic/), [Dysport®](/treatments/dysport/), [Xeomin®](/treatments/xeomin/), [Jeuveau®](/treatments/jeuveau/) and [DAXXIFY®](/treatments/daxxify/), and chooses the one that suits your face and your goals.

## What to expect

### Before

Your visit starts with a consultation with Dr. Quibell, who looks at how your face moves and plans where each injection goes.

### During

A few quick injections between the brows. A session is a short office visit, and you can go back to your day.

### After

In one large study, the median time to a visible result was three days, and people went about four months on average before their next treatment [4].

## Questions

**Q: How soon will I see results?**

Results can show in as little as one to three days.

**Q: How long does Letybo® last?**

In a large study, people went about four months on average before their next treatment. Dr. Quibell will plan your visits with you.

**Q: How is Letybo® different from other neuromodulators?**

Every neuromodulator relaxes the muscles behind expression lines, and each is made a little differently. Dr. Quibell offers them all and will help you choose the one that suits you.

**Q: Can Letybo® treat other lines?**

Letybo® is approved for frown lines. Dr. Quibell will talk with you about the lines you want to soften and the best way to treat each one.

Wellesley, Massachusetts

## Schedule Letybo® in Wellesley, MA

If you’re interested in what Letybo® can do for you, call [(781) 431-0002](tel:7814310002) or schedule your consultation online. We look forward to seeing you!

## References

> Letybo is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
— [U.S. Food and Drug Administration. Letybo (letibotulinumtoxinA-wlbg) approval letter, BLA 761225. February 29, 2024.](https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761225Orig1s000ltr.pdf)

> Letybo was studied in three randomized, multicenter, double-blind, placebo-controlled trials (BLESS I, BLESS II and BLESS III) in adults with moderate to severe glabellar lines.
— [U.S. Food and Drug Administration. Letybo (letibotulinumtoxinA-wlbg) prescribing information. 2024.](https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761225s000lbl.pdf)

> Visible results in as little as 1 to 3 days.
— [Hugel America. Letybo.](https://www.letybo.com/)

> In a phase 3 trial of letibotulinumtoxinA for glabellar lines, the median time to onset of effect was 3 days, and the mean time to first retreatment was 127 days.
— [Mueller DS, et al. Efficacy and safety of letibotulinumtoxinA in the treatment of glabellar lines: a randomized, double-blind, multicenter, placebo-controlled phase 3 study. Aesthet Surg J. 2022. PMID 35092418.](https://pubmed.ncbi.nlm.nih.gov/35092418/)


```ld+json
{
    "@context": "https://schema.org",
    "@graph": [
        {
            "@context": "https://schema.org",
            "@type": "Service",
            "@id": "https://www.mdtlc.com/treatments/letybo/#service",
            "name": "Letybo®",
            "url": "https://www.mdtlc.com/treatments/letybo/",
            "description": "Letybo® relaxes the muscles behind frown lines, with visible results in as little as one to three days.",
            "provider": {
                "@type": "Organization",
                "name": "MD TLC"
            }
        },
        {
            "@context": "https://schema.org",
            "@type": "MedicalWebPage",
            "@id": "https://www.mdtlc.com/treatments/letybo/#webpage",
            "name": "Letybo®",
            "url": "https://www.mdtlc.com/treatments/letybo/",
            "mainEntity": {
                "@id": "https://www.mdtlc.com/treatments/letybo/#service"
            },
            "speakable": {
                "@type": "SpeakableSpecification",
                "cssSelector": [
                    ".geo-summary"
                ]
            },
            "citation": [
                {
                    "@id": "https://www.mdtlc.com/treatments/letybo/#citation-893fde55"
                },
                {
                    "@id": "https://www.mdtlc.com/treatments/letybo/#citation-a1742588"
                },
                {
                    "@id": "https://www.mdtlc.com/treatments/letybo/#citation-18f71b6e"
                },
                {
                    "@id": "https://www.mdtlc.com/treatments/letybo/#citation-fc3e7e8f"
                }
            ]
        },
        {
            "@context": "https://schema.org",
            "@type": "BreadcrumbList",
            "itemListElement": [
                {
                    "@type": "ListItem",
                    "position": 1,
                    "name": "Home",
                    "item": {
                        "@id": "https://www.mdtlc.com/",
                        "@type": "WebSite",
                        "name": "Home"
                    }
                },
                {
                    "@type": "ListItem",
                    "position": 2,
                    "name": "Treatments",
                    "item": {
                        "@id": "https://www.mdtlc.com/treatments/",
                        "@type": "CollectionPage",
                        "name": "Treatments"
                    }
                },
                {
                    "@type": "ListItem",
                    "position": 3,
                    "name": "Letybo®",
                    "item": "https://www.mdtlc.com/treatments/letybo/"
                }
            ]
        },
        {
            "@context": "https://schema.org",
            "@type": "Question",
            "name": "Letybo®",
            "acceptedAnswer": {
                "@type": "Answer",
                "text": "Letybo® is a neuromodulator that smooths the frown lines between your brows by relaxing the muscles behind them. Approved in the US in 2024 and studied in three large trials, it can show results in as little as one to three days. Dr. Quibell offers it at MD TLC™ in Wellesley, MA."
            },
            "isPartOf": {
                "@id": "https://www.mdtlc.com/treatments/letybo/#webpage"
            },
            "url": "https://www.mdtlc.com/treatments/letybo/"
        },
        {
            "@context": "https://schema.org",
            "@type": "FAQPage",
            "mainEntity": [
                {
                    "@type": "Question",
                    "name": "How soon will I see results?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "<p>Results can show in as little as one to three days.</p>"
                    }
                },
                {
                    "@type": "Question",
                    "name": "How long does Letybo® last?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "<p>In a large study, people went about four months on average before their next treatment. Dr. Quibell will plan your visits with you.</p>"
                    }
                },
                {
                    "@type": "Question",
                    "name": "How is Letybo® different from other neuromodulators?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "<p>Every neuromodulator relaxes the muscles behind expression lines, and each is made a little differently. Dr. Quibell offers them all and will help you choose the one that suits you.</p>"
                    }
                },
                {
                    "@type": "Question",
                    "name": "Can Letybo® treat other lines?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "<p>Letybo® is approved for frown lines. Dr. Quibell will talk with you about the lines you want to soften and the best way to treat each one.</p>"
                    }
                }
            ]
        },
        {
            "@context": "https://schema.org",
            "@type": "CreativeWork",
            "@id": "https://www.mdtlc.com/treatments/letybo/#citation-893fde55",
            "name": "U.S. Food and Drug Administration. Letybo (letibotulinumtoxinA-wlbg) approval letter, BLA 761225. February 29, 2024.",
            "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761225Orig1s000ltr.pdf"
        },
        {
            "@context": "https://schema.org",
            "@type": "CreativeWork",
            "@id": "https://www.mdtlc.com/treatments/letybo/#citation-a1742588",
            "name": "U.S. Food and Drug Administration. Letybo (letibotulinumtoxinA-wlbg) prescribing information. 2024.",
            "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761225s000lbl.pdf"
        },
        {
            "@context": "https://schema.org",
            "@type": "Article",
            "@id": "https://www.mdtlc.com/treatments/letybo/#citation-18f71b6e",
            "name": "Hugel America. Letybo.",
            "url": "https://www.letybo.com/"
        },
        {
            "@context": "https://schema.org",
            "@type": "ScholarlyArticle",
            "@id": "https://www.mdtlc.com/treatments/letybo/#citation-fc3e7e8f",
            "name": "Mueller DS, et al. Efficacy and safety of letibotulinumtoxinA in the treatment of glabellar lines: a randomized, double-blind, multicenter, placebo-controlled phase 3 study. Aesthet Surg J. 2022. PMID 35092418.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/35092418/"
        }
    ]
}
```
